A Landmark Update: ASH and ISTH Release First Pediatric VTE Guidelines Since 2018
The International Society on Thrombosis and Haemostasis (ISTH) shared a proud post on X:
”Check it out! The American Society of Hematology (ASH) and ISTH Updated Guidelines on the Treatment of Pediatric VTE are featured in Hematology Advisor. Don’t miss this spotlight on our collaborative effort!
”
Read the full feature here.
‘These evidence-based guidelines are a key resource for clinicians to improve the quality of care for this vulnerable population,” said ASH President Belinda R. Avalos, MD.
ASH and ISTH have jointly published updated clinical guidelines for the management of pediatric venous thromboembolism (VTE), featured in Blood Advances.
These new recommendations reflect the latest evidence since ASH’s last update in 2018.
Developed by a multidisciplinary panel, the guidelines address critical aspects of pediatric VTE care—including decisions about whether to initiate treatment, management of acute thrombosis, and tailoring therapy to specific clinical scenarios.
In total, 16 recommendations were revised, and 4 new ones were introduced.
The updated guidelines represent a significant step forward in standardizing and advancing pediatric thrombosis care globally!
Latest advancements in hematology featured in Hemostasis Today.
-
Jul 11, 2025, 19:14ISTH 2025 for Cardiac Surgery: LEX-211 (FARES-II) Trial Shows Promising Results
-
Jul 11, 2025, 16:48GPAS 2025: Shaping the Future of Bleeding Disorder Care
-
Jul 10, 2025, 11:23HTRS Thanks CSL Behring for Its Ongoing Commitment to Research Support
-
Jul 9, 2025, 14:11Join Dr. Bethany Samuelson Bannow for a Virtual Event on Hemostasis and Cancer
-
Jul 9, 2025, 13:59Late-Breaking Insights from ISTH 2025: Rurioctocog Alfa Pegol in PUPs with Hemophilia A
-
Jul 12, 2025, 15:337 Tesla MRI Sheds Light on END Mechanisms in Symptomatic MCA Stenosis
-
Jul 12, 2025, 15:221 in 100: Subclavian Steal Syndrome Revealed by LVO Stroke in Case with Persistent Trigeminal Artery
-
Jul 11, 2025, 18:50ICAS Not a Factor: Post-EVT Intensive BP Control within 24 hrs Worsens Outcomes
-
Jul 11, 2025, 17:57Need for Recanalization Strategies Reinforced in P1 and P2: PCA Stroke Poor Outcomes
-
Jul 11, 2025, 15:40Wolfgang Miesbach: How to Better Understand and Explain Gene Therapy of Haemophilia?
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 6, 2025, 21:00From Untouchable to Editable: How 21st-Century Gene Editing Breakthroughs Clash with Systemic Barriers
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jul 6, 2025, 11:48Japan's Youth Engagement in Hemophilia Care: Where Even the Doctors Get It – HABIT Summit 2025